XML 53 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Collaboration Agreements, License Agreement and Revenues - Eluminex Agreement - Additional Information 2 (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2021
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2022
Dec. 31, 2023
Apr. 30, 2023
Dec. 31, 2022
Revenue Recognition, Milestone Method [Line Items]              
Total revenue   $ 2,739 $ 25,364        
Eluminex [Member]              
Revenue Recognition, Milestone Method [Line Items]              
Aggregate consideration received for milestone and upfront payments             $ 8,000
Future manufacturing clinical regulatory and commercial milestone payments $ 64,000            
Commercial milestone $ 36,000            
Additional upfront payments           $ 1,500  
Milestone Payments         $ 6,000    
Upfront payment         $ 1,500    
Total revenue   $ 0          
Eluminex [Member] | Cornea Products [Member]              
Revenue Recognition, Milestone Method [Line Items]              
Percentage of product manufacturing costs until manufacturing technology fully transferred       10.00%